Overstated Conclusions of a Pooled Analysis of Bevacizumab in Colon Cancer
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- January 20, 2006
has subject area
- 1103 Clinical Sciences (FoR)
- 1112 Oncology and Carcinogenesis (FoR)
- Antibodies, Monoclonal (MeSH)
- Antibodies, Monoclonal, Humanized (MeSH)
- Antineoplastic Combined Chemotherapy Protocols (MeSH)
- Bevacizumab (MeSH)
- Clinical Trials, Phase II as Topic (MeSH)
- Clinical Trials, Phase III as Topic (MeSH)
- Colonic Neoplasms (MeSH)
- Fluorouracil (MeSH)
- Humans (MeSH)
- Leucovorin (MeSH)
- Meta-Analysis as Topic (MeSH)
- Oncology & Carcinogenesis (Science Metrix)
- Randomized Controlled Trials as Topic (MeSH)
- Research Design (MeSH)
- Treatment Outcome (MeSH)
published in
- Journal of Clinical Oncology Journal